Literature DB >> 34415467

Novel variants in the NARS2 gene as a cause of infantile-onset severe epilepsy leading to fatal refractory status epilepticus: case study and literature review.

K Štěrbová1, M Vlčková2, H Hansíková3, V Sebroňová1, L Sedláčková1, P Pavlíček4, Petra Laššuthová5.   

Abstract

Biallelic variants in the NARS2 gene are the cause of a continuous spectrum of neurodegenerative disorders presenting with various severity-from spastic paraplegia, progressive neurodegeneration to Leigh and Alpers syndrome. Common clinical signs result from a mitochondrial dysfunction based on OXPHOS deficiency. Here, we present a patient with infantile-onset severe epilepsy leading to fatal refractory status epilepticus. Whole exome sequencing with Exomiser analysis based on HPO terms detected two novel NARS2 variants in a compound heterozygous state. To date, 18 different NARS2 disease-causing mutations have been described. Our study adds to the understanding of this mitochondrial disorder.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Epilepsy; Exomiser; NARS2; Neurodegeneration; Variant; Whole exome sequencing

Mesh:

Substances:

Year:  2021        PMID: 34415467     DOI: 10.1007/s10048-021-00659-0

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  18 in total

Review 1.  Aminoacyl-tRNA synthesis.

Authors:  M Ibba; D Soll
Journal:  Annu Rev Biochem       Date:  2000       Impact factor: 23.643

Review 2.  Mitochondrial aminoacyl-tRNA synthetases in human disease.

Authors:  Svetlana Konovalova; Henna Tyynismaa
Journal:  Mol Genet Metab       Date:  2013-01-26       Impact factor: 4.797

3.  PhastWeb: a web interface for evolutionary conservation scoring of multiple sequence alignments using phastCons and phyloP.

Authors:  Ritika Ramani; Katie Krumholz; Yi-Fei Huang; Adam Siepel
Journal:  Bioinformatics       Date:  2019-07-01       Impact factor: 6.937

4.  MutationTaster2: mutation prediction for the deep-sequencing age.

Authors:  Jana Marie Schwarz; David N Cooper; Markus Schuelke; Dominik Seelow
Journal:  Nat Methods       Date:  2014-04       Impact factor: 28.547

5.  PARS2 and NARS2 mutations in infantile-onset neurodegenerative disorder.

Authors:  Takeshi Mizuguchi; Mitsuko Nakashima; Mitsuhiro Kato; Keitaro Yamada; Tohru Okanishi; Nina Ekhilevitch; Hanna Mandel; Ayelet Eran; Miyuki Toyono; Yukio Sawaishi; Hirotaka Motoi; Masaaki Shiina; Kazuhiro Ogata; Satoko Miyatake; Noriko Miyake; Hirotomo Saitsu; Naomichi Matsumoto
Journal:  J Hum Genet       Date:  2017-01-12       Impact factor: 3.172

6.  In silico analysis of missense substitutions using sequence-alignment based methods.

Authors:  Sean V Tavtigian; Marc S Greenblatt; Fabienne Lesueur; Graham B Byrnes
Journal:  Hum Mutat       Date:  2008-11       Impact factor: 4.878

7.  A method and server for predicting damaging missense mutations.

Authors:  Ivan A Adzhubei; Steffen Schmidt; Leonid Peshkin; Vasily E Ramensky; Anna Gerasimova; Peer Bork; Alexey S Kondrashov; Shamil R Sunyaev
Journal:  Nat Methods       Date:  2010-04       Impact factor: 28.547

8.  SIFT web server: predicting effects of amino acid substitutions on proteins.

Authors:  Ngak-Leng Sim; Prateek Kumar; Jing Hu; Steven Henikoff; Georg Schneider; Pauline C Ng
Journal:  Nucleic Acids Res       Date:  2012-06-11       Impact factor: 16.971

9.  Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Authors:  Sue Richards; Nazneen Aziz; Sherri Bale; David Bick; Soma Das; Julie Gastier-Foster; Wayne W Grody; Madhuri Hegde; Elaine Lyon; Elaine Spector; Karl Voelkerding; Heidi L Rehm
Journal:  Genet Med       Date:  2015-03-05       Impact factor: 8.822

10.  The mutational constraint spectrum quantified from variation in 141,456 humans.

Authors:  Konrad J Karczewski; Laurent C Francioli; Grace Tiao; Beryl B Cummings; Jessica Alföldi; Qingbo Wang; Ryan L Collins; Kristen M Laricchia; Andrea Ganna; Daniel P Birnbaum; Laura D Gauthier; Harrison Brand; Matthew Solomonson; Nicholas A Watts; Daniel Rhodes; Moriel Singer-Berk; Eleina M England; Eleanor G Seaby; Jack A Kosmicki; Raymond K Walters; Katherine Tashman; Yossi Farjoun; Eric Banks; Timothy Poterba; Arcturus Wang; Cotton Seed; Nicola Whiffin; Jessica X Chong; Kaitlin E Samocha; Emma Pierce-Hoffman; Zachary Zappala; Anne H O'Donnell-Luria; Eric Vallabh Minikel; Ben Weisburd; Monkol Lek; James S Ware; Christopher Vittal; Irina M Armean; Louis Bergelson; Kristian Cibulskis; Kristen M Connolly; Miguel Covarrubias; Stacey Donnelly; Steven Ferriera; Stacey Gabriel; Jeff Gentry; Namrata Gupta; Thibault Jeandet; Diane Kaplan; Christopher Llanwarne; Ruchi Munshi; Sam Novod; Nikelle Petrillo; David Roazen; Valentin Ruano-Rubio; Andrea Saltzman; Molly Schleicher; Jose Soto; Kathleen Tibbetts; Charlotte Tolonen; Gordon Wade; Michael E Talkowski; Benjamin M Neale; Mark J Daly; Daniel G MacArthur
Journal:  Nature       Date:  2020-05-27       Impact factor: 69.504

View more
  3 in total

1.  Study of novel NARS2 variants in patient of combined oxidative phosphorylation deficiency 24.

Authors:  Yi Zhang; Xiangyue Zhao; Yufei Xu; Lina Chen; Niu Li; Ruen Yao; Xiumin Wang; Jian Wang; Tingting Yu
Journal:  Transl Pediatr       Date:  2022-04

2.  Fatal status epilepticus: the broad phenotypic heterogeneity of NARS2 variants.

Authors:  J Finsterer
Journal:  Neurogenetics       Date:  2021-11-15       Impact factor: 2.660

3.  Novel NARS2 variant causing leigh syndrome with normal lactate levels.

Authors:  Ryosuke Tanaka; Ryo Takeguchi; Mami Kuroda; Nao Suzuki; Yoshio Makita; Kumiko Yanagi; Tadashi Kaname; Satoru Takahashi
Journal:  Hum Genome Var       Date:  2022-05-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.